Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lunestil is a multi-ingredient dietary supplement developed by Euro Generics (a subsidiary of the STADA Group) for the management of sleep disturbances and mild insomnia. The product utilizes a unique 'duo capsule' technology—a capsule within a capsule—designed for the sequential release of its four primary components: English lavender oil (Lavandula angustifolia), passionflower extract (Passiflora incarnata), melatonin, and vitamin B6 (pyridoxine). The outer capsule releases lavender oil to promote relaxation and mental ease before bedtime, while the inner capsule subsequently releases melatonin, passionflower, and vitamin B6 to support sleep onset and a healthy night's rest. It is marketed as a non-habit-forming sleep aid that does not cause morning drowsiness or grogginess.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lunestil.